Bioaffinity technologies announces targeted actions to cut $4 million in costs and drive cypath® lung sales growth

San antonio--(business wire)-- #biaf--bioaffinity technologies today announced strategic actions to cut $4 million in annual costs at its subsidiary cap/clia pathology laboratory.

BIAF Ratings Summary

BIAF Quant Ranking